151 related articles for article (PubMed ID: 33560084)
1. Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration.
Hoover A; Zimmerman JAO; Wiese S; Modi A
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1010-e1014. PubMed ID: 33560084
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of empiric vancomycin therapy in children with fever and neutropenia.
Adcock KG; Akins RL; Farrington EA
Pharmacotherapy; 1999 Nov; 19(11):1315-20. PubMed ID: 10555937
[TBL] [Abstract][Full Text] [Related]
3. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
[TBL] [Abstract][Full Text] [Related]
4. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
Snyder M; Pasikhova Y; Baluch A
Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
[TBL] [Abstract][Full Text] [Related]
6. Ara-C fever and infections after high-dose ara-C treatment in pediatric lymphoid malignancies.
Ek T; Pinkava M; Abrahamsson J
J Pediatr Hematol Oncol; 2005 Jul; 27(7):364-9. PubMed ID: 16012325
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
[TBL] [Abstract][Full Text] [Related]
8. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
Bradley AM; Deal AM; Buie LW; van Deventer H
Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic use during cytarabine consolidation in acute myeloid leukemia.
Vale CA; Egan PC; Ingham R; Farmakiotis D; Reagan JL
Ann Hematol; 2021 Jan; 100(1):79-84. PubMed ID: 32870366
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia.
Fukushima T; Urasaki Y; Yamaguchi M; Ueda M; Morinaga K; Haba T; Sugiyama T; Nakao S; Origasa H; Umehara H; Ueda T
Anticancer Res; 2012 Feb; 32(2):643-7. PubMed ID: 22287757
[TBL] [Abstract][Full Text] [Related]
11. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Bossaer JB; Hall PD; Garrett-Mayer E
Support Care Cancer; 2010 Feb; 19(2):231-7. PubMed ID: 20069435
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
14. [Infection caused by viridans streptococci in children with malignant hematologic diseases].
Rieske K; Handrick W; Spencker FB; Günther E
Klin Padiatr; 1997; 209(6):364-72. PubMed ID: 9445921
[TBL] [Abstract][Full Text] [Related]
15. Fever in children with sickle cell disease: are all fevers equal?
Shihabuddin BS; Scarfi CA
J Emerg Med; 2014 Oct; 47(4):395-400. PubMed ID: 25161094
[TBL] [Abstract][Full Text] [Related]
16. Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia.
Loeb DM; Bowers DC; Civin CI; Friedman AD
Med Pediatr Oncol; 2001 Oct; 37(4):365-71. PubMed ID: 11568900
[TBL] [Abstract][Full Text] [Related]
17. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
[TBL] [Abstract][Full Text] [Related]
18. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
20. Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.
Löwenberg B
Blood; 2013 Jan; 121(1):26-8. PubMed ID: 23287624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]